尔康制药
(300267)
| 流通市值：46.65亿 | | | 总市值：67.65亿 |
| 流通股本：14.22亿 | | | 总股本：20.63亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 884,313,345.86 | 976,834,945.24 | 897,404,913.83 | 709,202,365.93 |
| 交易性金融资产 | 20,000,000 | 90,000,000 | 90,000,000 | 90,000,000 |
| 衍生金融资产 | 2,562,100 | - | - | 762,746.79 |
| 应收票据及应收账款 | 187,260,615.63 | 163,181,967.78 | 155,784,775.56 | 158,238,311.24 |
| 其中：应收票据 | 30,935,880.58 | 33,964,991.3 | 34,792,695.91 | 28,718,737.52 |
| 应收账款 | 156,324,735.05 | 129,216,976.48 | 120,992,079.65 | 129,519,573.72 |
| 应收款项融资 | 29,288,355.94 | 38,942,196.86 | 46,609,251.17 | 46,348,208.7 |
| 预付款项 | 21,163,051.46 | 43,456,373.73 | 4,342,448.49 | 7,711,330.94 |
| 其他应收款合计 | 2,386,979.66 | 3,529,862.48 | 3,622,884.22 | 3,763,018.26 |
| 存货 | 750,164,570.12 | 523,930,100.38 | 511,995,309.66 | 574,294,141.02 |
| 其他流动资产 | 76,385,479.43 | 79,273,211.61 | 78,805,318.31 | 183,743,187.05 |
| 流动资产合计 | 1,973,524,498.1 | 1,919,148,658.08 | 1,788,564,901.24 | 1,774,063,309.93 |
| 非流动资产: | | | | |
| 长期股权投资 | 49,591,253.68 | 49,753,379.52 | 49,796,115.43 | 71,902,577.34 |
| 其他权益工具投资 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 投资性房地产 | 73,274,354.87 | 74,075,724.67 | 74,877,094.52 | 75,678,464.32 |
| 固定资产 | 1,995,501,401.73 | 2,024,647,726.09 | 2,052,034,605.35 | 2,287,013,221.83 |
| 在建工程 | 192,680,667.39 | 203,474,658.59 | 212,280,768.93 | 225,861,386.29 |
| 使用权资产 | 151,332,348.82 | 156,221,733.02 | 161,011,810.33 | 164,980,432.62 |
| 无形资产 | 307,836,529.72 | 312,643,182.3 | 317,123,214.89 | 348,585,635.76 |
| 商誉 | 2,003,166.56 | 2,003,166.56 | 2,003,166.56 | 2,003,166.56 |
| 长期待摊费用 | 8,097,455.23 | 8,889,167.4 | 9,562,210.31 | 10,266,723.11 |
| 递延所得税资产 | 112,988,761.87 | 119,801,334.85 | 120,402,235.4 | 148,136,132.48 |
| 其他非流动资产 | 62,997,546.1 | 38,830,879.72 | 23,368,123.24 | 44,181,917.99 |
| 非流动资产合计 | 3,006,303,485.97 | 3,040,340,952.72 | 3,072,459,344.96 | 3,428,609,658.3 |
| 资产总计 | 4,979,827,984.07 | 4,959,489,610.8 | 4,861,024,246.2 | 5,202,672,968.23 |
| 流动负债: | | | | |
| 短期借款 | 689,333,333.32 | 684,508,487.65 | 551,383,098.76 | 484,025,320.99 |
| 应付票据及应付账款 | 142,946,446.34 | 113,472,017.86 | 121,072,034.17 | 108,436,127.25 |
| 应付账款 | 142,946,446.34 | 113,472,017.86 | 121,072,034.17 | 108,436,127.25 |
| 合同负债 | 30,826,672.61 | 39,538,415.37 | 26,174,437.99 | 37,899,091.02 |
| 应付职工薪酬 | 14,913,319.94 | 12,414,386.77 | 25,007,592.2 | 8,987,855 |
| 应交税费 | 5,179,050.24 | 3,136,590.67 | 8,745,803.43 | 2,574,431.76 |
| 其他应付款合计 | 40,334,781.91 | 40,467,336.54 | 44,163,226.06 | 29,060,465.49 |
| 一年内到期的非流动负债 | 7,885,682.23 | 4,823,476.1 | 8,787,182.79 | 8,897,807.25 |
| 其他流动负债 | 18,580,602.61 | 18,545,378.44 | 17,393,561.31 | 12,424,291.16 |
| 流动负债合计 | 949,999,889.2 | 916,906,089.4 | 802,726,936.71 | 692,305,389.92 |
| 非流动负债: | | | | |
| 租赁负债 | 23,628,454.73 | 27,715,257.2 | 27,858,917.41 | 27,645,980.83 |
| 预计负债 | - | - | - | 12,993,511.88 |
| 递延收益 | 8,336,749.56 | 9,197,888.29 | 10,059,027.01 | 11,261,165.59 |
| 递延所得税负债 | 44,720,626.33 | 46,354,118.38 | 46,324,267.52 | 46,427,163.81 |
| 非流动负债合计 | 76,685,830.62 | 83,267,263.87 | 84,242,211.94 | 98,327,822.11 |
| 负债合计 | 1,026,685,719.82 | 1,000,173,353.27 | 886,969,148.65 | 790,633,212.03 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,062,604,870 | 2,062,604,870 | 2,062,604,870 | 2,062,604,870 |
| 资本公积 | 1,019,459,930.44 | 1,019,459,930.44 | 1,019,459,930.44 | 1,019,459,930.44 |
| 其他综合收益 | -29,594,433.36 | 1,494,544.09 | 26,858,716.61 | 42,711,554.72 |
| 专项储备 | 1,370,431.97 | 1,236,897.27 | 1,096,278.59 | 1,153,611.57 |
| 盈余公积 | 138,000,248.18 | 138,000,248.18 | 138,000,248.18 | 138,000,248.18 |
| 未分配利润 | 830,583,330.59 | 799,381,775.12 | 786,273,191.36 | 1,205,666,707.23 |
| 归属于母公司股东权益合计 | 4,022,424,377.82 | 4,022,178,265.1 | 4,034,293,235.18 | 4,469,596,922.14 |
| 少数股东权益 | -69,282,113.57 | -62,862,007.57 | -60,238,137.63 | -57,557,165.94 |
| 股东权益合计 | 3,953,142,264.25 | 3,959,316,257.53 | 3,974,055,097.55 | 4,412,039,756.2 |
| 负债和股东权益合计 | 4,979,827,984.07 | 4,959,489,610.8 | 4,861,024,246.2 | 5,202,672,968.23 |
| 公告日期 | 2026-08-27 | 2026-04-24 | 2026-04-23 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |